Psilocybin Therapy

Watch the Panel recently hosted at the UW Law School Center for Law in Science & Global Health on the Right To Try effort as a means to open access to Psilocybin Therapy featuring AIMS Institute Co-director Dr. Sunil Aggarwal.

RECENT DEVELOPMENTS REGARDING ACCESS TO PSILOCYBEN THERAPY, DECEMBER 14, 2020
This conference discussed recent innovative efforts to remove barriers to access to psilocybin. In recent years there has been increasing interest in use of psychedelics for relief of anxiety and depression at the end of life, treatment of depression, and post-traumatic stress disorder. Our speakers discussed recent developments from legal, medical, mental health and advocacy perspectives.

Font Resize
Contrast
Call Us Text Us